Disclosures for "Safety and Efficacy of Dual Antiplatelet Therapy in Patients with Minor Ischemic Stroke or High-risk Transient Ischemic Attack After Intravenous Thrombolysis"
-
Mrs. Balcarce has nothing to disclose.
-
Marian Trentadue has nothing to disclose.
-
Dr. Alet has nothing to disclose.
-
Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.